Neoadjuvant chemotherapy cannot be regarded as adequate routine therapy strategy of advanced ovarian cancer.

Authors :: du Bois A
Marth C
Pfisterer J
Harter P
Hilpert F
Zeimet AG
Sehouli J
Source :: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2012 Feb; Vol. 22 (2), pp. 182-5.
Publication Year :: 2012
Abstract: Minority vote to statement A5 of the Fourth Ovarian Cancer Consensus Conference, Vancouver 2010, on behalf of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group Germany plus North-Eastern Society of Gyneco-Oncology and the AGO Austria.

Subjects :: Austria
Female
Germany
Humans
Neoplasm Staging
Ovarian Neoplasms pathology
Women's Health
Antineoplastic Combined Chemotherapy Protocols administration & dosage
Consensus Development Conferences as Topic
Neoadjuvant Therapy
Ovarian Neoplasms therapy
Practice Patterns, Physicians'

Language :: English
ISSN :: 1525-1438
Volume :: 22
Issue :: 2
Database :: MEDLINE
Journal :: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Publication Type :: Academic Journal
Accession number :: 22274314
Full Text :: https://doi.org/10.1097/IGC.0b013e31821d419a

Full Text Access

Tools